EUZ — Eckert & Ziegler SE Share News
0.000.00%
Last trade - 00:00- €770.94m
- €703.00m
- €311.96m
Brief: Eckert & Ziegler Announces Changes In The Executive Board And Supervisory Board
Brief: Eckert & Ziegler Says EC Approves Eckert & Ziegler's Theralugand
Brief: Eckert & Ziegler Raises Forecast For Current Financial Year
Brief: Eckert & Ziegler Sees FY Revenue Around EUR 265 Million
Brief: Eckert & Ziegler And Telix Pharmaceuticals Enter Into Collaboration And Licence Agreement For Actinium-225
Brief: Eckert & Ziegler Q3 Sales At EUR 70.1 Mln
Brief: Eckert & Ziegler 9M Net Income EUR 5.3 Million
Brief: Eckert & Ziegler And Glytherix Sign Agreement For Lutetium-177 Supply
Brief: Eckert & Ziegler Says Spin-Off Of Pentixapharm Registered
Brief: Pentixapharm Holding AG Says IPO Placement Price Set At 5.10 Euros/Share, All 3.9 Mln Offer Shares Placed
Brief: Pentixapharm Sets Price Range For Planned IPO
Brief: Eckert & Ziegler - Pentixapharm Holding AG, A Subsidiary Of Eckert & Ziegler SE, Plans IPO On Prime Standard Of Frankfurt Stock Exchange
Brief: Eckert & Ziegler Becomes European Contract Manufacturer For Telix's Phase III Prostact Global Study
Brief: Eckert & Ziegler Q2 Sales Eur 77.8 Mln Vs Eur 60.1 Mln Last Year
Brief: Eckert & Ziegler Extends Galliapharm® Availability To Entire European Economic Area
Brief: Eckert & Ziegler H1 Net Income At EUR 18.0 Mln
Brief: Eckert & Ziegler H1 Net Income EUR 9.5 Million
Brief: EMA Says Valneva's Chikungunya Vaccine Receives Positive CHMP Opinion
Brief: Eckert & Ziegler Confirms FY Forecast